
==== Front
Ann OncolAnn. OncolannoncAnnals of Oncology0923-75341569-8041Oxford University Press 10.1093/annonc/mdx807mdx807CorrigendaFinal overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC Knox J J Barrios C H Kim T M Cosgriff T Srimuninnimit V Pittman K Sabbatini R Rha S Y Flaig T W Page R D Beck J T Cheung F Yadav S Patel P Geoffrois L Niolat J Berkowitz N Marker M Chen D Motzer R J 11 2018 29 1 2018 29 1 2018 29 11 Endogenous retroviruses and their implications for immunotherapy2269 2269 © The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology.2018This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
==== Body
Ann Oncol 2017; 28: 1339–1345 (doi: 10.1093/annonc/mdx075)

In the original article, Figure 2B incorrectly described the curves as PFS, while it should have read OS. This has now been corrected.

